CPBIO Holding Company Limited (HKG:3839)
8.80
+0.05 (0.57%)
Aug 27, 2026, 4:08 PM HKT
CPBIO Holding Company Market Cap
CPBIO Holding Company has a market cap or net worth of 2.22 billion as of August 26, 2026. Its market cap has increased by 27.00% in one year.
Market Cap
2.22B
Enterprise Value
2.77B
Revenue
3.32B
Ranking
n/a
PE Ratio
11.57
Stock Price
8.80
ChartMarket Cap Chart
Since July 3, 2015, CPBIO Holding Company's market cap has increased from 1.45B to 2.22B, an increase of 53.24%. That is a compound annual growth rate of 3.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 2.22B | 20.69% |
| Dec 31, 2025 | 1.84B | 386.58% |
| Dec 31, 2024 | 377.46M | 56.84% |
| Dec 29, 2023 | 240.66M | 43.94% |
| Dec 30, 2022 | 167.20M | -52.17% |
| Dec 31, 2021 | 349.59M | -0.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xuanzhu Biopharmaceutical | 5.36B |
| Beijing Tong Ren Tang Chinese Medicine Company | 5.32B |
| Edding Genor Group Holdings | 2.91B |
| Hua Medicine (Shanghai) | 2.55B |
| VISEN Pharmaceuticals | 2.18B |
| Jacobson Pharma Corporation | 2.12B |
| Golden Throat Holdings Group Company | 1.67B |
| JBM (Healthcare) | 1.56B |